High-Dose Dexmedetomidine Promotes Apoptosis in Fetal Rat Hippocampal Neurons

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Dexmedetomidine (DEX) is an alpha-2 adrenoceptor agonist with sedative, analgesic, and anxiolytic properties.
• DEX is widely used in anesthesia and intensive care units (ICUs).
• High concentrations of DEX may exhibit neurotoxic effects, including neuronal apoptosis.

Purpose of the Study:

• To investigate the potential proapoptotic effects of DEX on fetal rat hippocampal neurons.
• To evaluate the impact of varying DEX concentrations on neuronal cell viability and apoptosis.

Main Methods:

• Primary hippocampal neurons were cultured in vitro.
• Cells were exposed to different DEX concentrations.
• Cell viability (CCK-8 assay), apoptosis (flow cytometry), protein expression (Western blotting), mitochondrial ATP, membrane potential (Δψm), and reactive oxygen species (ROS) were analyzed.

Main Results:

• High DEX concentrations (≥100 μM) significantly reduced cell viability and induced apoptosis.
• DEX upregulated pro-apoptotic proteins (cleaved caspase-3, caspase-9, Bax, Cyt-c) and ROS production.
• DEX downregulated anti-apoptotic protein (Bcl-2), decreased mitochondrial membrane potential, and reduced ATP synthesis.

Conclusions:

• High concentrations of DEX demonstrate neurotoxic effects on fetal rat hippocampal neurons.
• DEX induces apoptosis in these neurons through mechanisms involving mitochondrial pathways and oxidative stress.